Evidence map›Paper›PMID 35239131›Full record

ArticleActa neurologica Belgica2022

Autonomic dysfunction in patients with COVID‑19.

Yuksel Erdal, Arife Cimen Atalar, Taskın Gunes, Tugba Okluoglu, Nurettin Yavuz, Ufuk Emre

Abstract read
In one paragraph

Article in Acta neurologica Belgica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuksel ErdalDepartment of Neurology, Health Sciences University, Istanbul Training and Research Hospital, Istanbul, Turkey. erdalyuksel_355@hotmail.com.ORCID http://orcid.org/0000-0002-5338-3901
Arife Cimen AtalarDepartment of Neurology, Health Sciences University, Istanbul Training and Research Hospital, Istanbul, Turkey.
Taskın GunesDepartment of Neurology, Bahcesehir University, VM Maltepe Medical Park Hospital, Istanbul, Turkey.
Tugba OkluogluDepartment of Neurology, Health Sciences University, Istanbul Training and Research Hospital, Istanbul, Turkey.
Nurettin YavuzDepartment of Neurology, Health Sciences University, Istanbul Training and Research Hospital, Istanbul, Turkey.
Ufuk EmreDepartment of Neurology, Health Sciences University, Istanbul Training and Research Hospital, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAutonomic dysfunction in patients with viral infections has been described before. In this study, we aimed to evaluate autonomic functions in patients with the coronavirus infectious disease 2019 (COVİD-19).

methodsIn this cross-sectional study, we compared 112 patients who had recovered from COVID-19 and 106 healthy controls. Symptoms of autonomic dysfunction were assessed with the SCOPA-AUT scale.

resultsPupillomotor, urinary and sudomotor subscores of SCOPA-AUT scale were significantly higher in the COVID-19 patient group (p = 0.03, p = 0,006, p = 0.0001, respectively). There were no significant difference in terms of gastrointestinal, cardiovascular, sexual subscores and total SCOPA-AUT scores between the patient and control groups. The presence of fatigue symptom in the acute phase of COVID-19 increased the total SCOPA-AUT score by 2.2 points (p = 0.04) whereas the presence of smell loss (OR = 5.82, p = 0.01) and dyspnea (OR = 5.8, p = 0.03) were significant risk factors for pupillomotor dysfunction. The urinary, cardiovascular, sexual subscores and the total score of SCOPA-AUT scale were positively correlated with the age of the patient group.

conclusionOur study suggests that many patients might have prolonged symptoms of autonomic dysfunction after the acute phase of COVID-19 that might worsen the clinical recovery.

Indexed as

Autonomic Nervous System DiseasesCommunicable DiseasesCOVID-19Cross-Sectional StudiesHumansSurveys and QuestionnairesAutonomic dysfunctionCOVID-19SCOPA-AUTSudomotor

Identifiers

PMID35239131
PMCPMC8891732

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.